Childhood Cerebral X-Linked Adrenoleukodystrophy: Diffusion Tensor Imaging Measurements for Prediction of Clinical Outcome after Hematopoietic Stem Cell Transplantation

References

1. 1.↵
   1. Scriver CR,
   2. Beaudet AL,
   3. Sly WS,
   4. et al.

   1. Moser HW,
   2. Smith KD,
   3. Watkins PA,
   4. et al

   . X-linked adrenoleukodystrophy. In: Scriver CR, Beaudet AL, Sly WS, et al., eds. The Metabolic and Molecular Bases of Inherited Disease 8th ed. New York: McGraw-Hill; 2001:3257–301
2. 2.↵
   1. Bezman L,
   2. Moser HW

   . Incidence of X-linked adrenoleukodystrophy and the relative frequency of its phenotypes. Am J Med Genet 1998;76:415–19

   CrossRefPubMedWeb of Science
3. 3.↵
   1. Moser HW,
   2. Loes DJ,
   3. Melhem ER,
   4. et al

   . X-linked adrenoleukodystrophy: overview and prognosis as a function of age and brain magnetic resonance imaging abnormality. A study involving 372 patients. Neuropediatrics 2000;31:227–39

   CrossRefPubMedWeb of Science
4. 4.↵
   1. Moser H,
   2. Raymond G,
   3. Koehler W,
   4. et al

   . Evaluation of the preventive effect of glyceryl trioleate-trierucate (“Lorenzo's oil”) therapy in X-linked adrenoleukodystrophy: results of two concurrent trials. Adv Exp Med Biol 2003;544:369–87

   PubMedWeb of Science
5. 5.↵
   1. Miller WP,
   2. Rothman SM,
   3. Nascene D,
   4. et al

   . Outcomes following allogeneic hematopoietic cell transplantation for childhood cerebral adrenoleukodystrophy: the largest single-institution cohort report. Blood 2011;118:1971–78

   Abstract/FREE Full Text
6. 6.↵
   1. Peters C,
   2. Charnas LR,
   3. Tan Y,
   4. et al

   . Cerebral X-linked adrenoleukodystrophy: the international hematopoietic cell transplantation experience from 1982 to 1999. Blood 2004;104:881–88

   Abstract/FREE Full Text
7. 7.↵
   1. Tolar J,
   2. Orchard PJ,
   3. Bjoraker KJ,
   4. et al

   . N-acetyl-L-cysteine improves outcome of advanced cerebral adrenoleukodystrophy. Bone Marrow Transplant 2007;39:211–15

   CrossRefPubMed
8. 8.↵
   1. Loes DJ,
   2. Hite S,
   3. Moser H,
   4. et al

   . Adrenoleukodystrophy: a scoring method for brain MR observations. AJNR Am J Neuroradiol 1994;15:1761–66

   Abstract/FREE Full Text
9. 9.↵
   1. Powers JM,
   2. Pei Z,
   3. Heinzer AK,
   4. et al

   . Adrenoleukodystrophy: oxidative stress of mice and men. J Neuropathol Exp Neurol 2005;64:1067–79

   CrossRefPubMedWeb of Science
10. 10.↵
    1. Orchard PJ,
    2. Tolar J

    . Transplant outcomes in leukodystrophies. Semin Hematol 2010;47:70–78

    CrossRefPubMed
11. 11.↵
    1. Melhem ER,
    2. Barker PB,
    3. Raymond GV,
    4. et al

    . X-linked adrenoleukodystrophy in children: review of genetic, clinical, and MR imaging characteristics. AJR Am J Roentgenol 1999;173:1575–81

    PubMed
12. 12.↵
    1. Ito R,
    2. Melhem ER,
    3. Mori S,
    4. et al

    . Diffusion tensor brain MR imaging in X-linked cerebral adrenoleukodystrophy. Neurology 2001;56:544–47

    CrossRef
13. 13.↵
    1. Eichler FS,
    2. Itoh R,
    3. Barker PB,
    4. et al

    . Proton MR spectroscopic and diffusion tensor brain MR imaging in X-linked adrenoleukodystrophy: initial experience. Radiology 2002;225:245–52

    CrossRefPubMedWeb of Science
14. 14.↵
    1. Schneider JF,
    2. Il'yasov KA,
    3. Boltshauser E,
    4. et al

    . Diffusion tensor imaging in cases of adrenoleukodystrophy: preliminary experience as a marker for early demyelination? AJNR Am J Neuroradiol 2003;24:819–24

    Abstract/FREE Full Text
15. 15.↵
    1. van der Voorn JP,
    2. Pouwels PJ,
    3. Powers JM,
    4. et al

    . Correlating quantitative MR imaging with histopathology in X-linked adrenoleukodystrophy. AJNR Am J Neuroradiol 2011;32:481–89

    Abstract/FREE Full Text
16. 16.↵
    1. Westin CF,
    2. Maier SE,
    3. Mamata H,
    4. et al

    . Processing and visualization for diffusion tensor MRI. Med Image Anal 2002;6:93–108

    CrossRefPubMedWeb of Science
17. 17.↵
    1. Basser PJ,
    2. Pierpaoli C

    . Microstructural and physiological features of tissues elucidated by quantitative-diffusion-tensor MRI. J Magn Reson B 1996;111:209–19

    CrossRefPubMedWeb of Science
18. 18.↵
    1. Benjamini Y,
    2. Hochberg Y

    . Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Series B Stat Methodol 1995;57:289–300
19. 19.↵
    1. Yonke B,
    2. Krenzel C,
    3. McKinney AM

    . Patterns of restricted diffusion in adrenoleukodystrophy after bone marrow transplant. Presented at the Annual Meeting of the American Society of Neuroradiology, April 29–May 5, 2006; San Diego, California
20. 20.↵
    1. Guo A,
    2. Petrella JR,
    3. Kurtzberg J,
    4. et al

    . Evaluation of white matter anisotropy in Krabbe disease using diffusion tensor MR imaging. Radiology 2001;218:809–15

    CrossRefPubMedWeb of Science
21. 21.↵
    1. McGraw P,
    2. Liang L,
    3. Escolar M,
    4. et al

    . Krabbe disease treated with hematopoietic stem cell transplantation: serial assessment of anisotropy measurements—initial experience. Radiology 2005;236:221–30

    CrossRefPubMedWeb of Science
22. 22.↵
    1. Pouwels PJW,
    2. Kruse B,
    3. Korenke GC,
    4. et al

    . Quantitative proton magnetic resonance spectroscopy of childhood adrenoleukodystrophy. Neuropediatrics 1998;29:254–64

    CrossRefPubMed
23. 23.↵
    1. Beitinjaneh A,
    2. McKinney AM,
    3. Cao Q,
    4. et al

    . Toxic leukoencephalopathy following fludarabine-associated hematopoietic cell transplantation. Biol Blood Marrow Transplant 2011;17:300–08

    CrossRefPubMed
24. 24.↵
    1. McKinney AM,
    2. Kieffer SA,
    3. Paylor RT,
    4. et al

    . Acute toxic leukoencephalopathy: potential for reversibility clinically and on MRI with diffusion-weighted and FLAIR imaging. AJR Am J Roentgenol 2009;193:192–206

    CrossRefPubMedWeb of Science
25. 25.↵
    1. Wechsler D

    . Wechsler Intelligence Scale for Children 4th ed. (WISC-IV). San Antonio: Psychological Corporation; 2003
26. 26.↵
    1. Wechsler D

    . Wechsler Preschool and Primary Scale of Intelligence 3rd ed. (WPPSI–III). San Antonio: Psychological Corporation; 2002
27. 27.↵
    1. Wechsler D

    . Wechsler Abbreviated Scale of Intelligence. San Antonio: Psychological Corporation; 1999
28. 28.↵
    1. Beery KE,
    2. Buktenica NA,
    3. Beery NA

    . The Beery-Buktenica Developmental Test of Visual-Motor Integration. Minneapolis: NCS Pearson, Inc; 2004
29. 29.↵
    1. Sparrow SS,
    2. Balla DA,
    3. Cicchetti DV

    . Vineland Adaptive Behavior Scales. Circle Pines, Minnesota: American Corporation; 1991